# FDA Inspection 1054877 - Harbinger Medical Group - May 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/harbinger-medical-group/1d7df9aa-8d80-4e2d-9ddd-9891bf081400
Source feed: FDA_Inspections

> FDA Inspection 1054877 for Harbinger Medical Group on May 22, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1054877
- Company Name: Harbinger Medical Group
- Inspection Date: 2018-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1195197 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/harbinger-medical-group/e067be2f-eec8-4df9-a8bb-8dc2762309f6)
- [FDA Inspection 1195197 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/harbinger-medical-group/724a1aec-3de8-4df5-bc0c-f5d5532401e1)
- [FDA Inspection 1195197 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/harbinger-medical-group/d4887459-a46e-43cc-b1c2-c9fd88fb7f5e)
- [FDA Inspection 900010 - 2014-10-15](https://www.keypedia.com/records/fda_inspections/harbinger-medical-group/21308baf-2ea7-4389-a4a8-3d8e1f328fa7)

Company: https://www.keypedia.com/companies/harbinger-medical-group/9497f3bf-0729-4f73-90d4-b417373bb1fd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d